CDX2 and colorectal carcinoma: More recently, it is found that the activation of FXR and the inhibition of EZH2, a histone-lysine N-methyltransferase, synergistically inhibit CRC through accelerating the FXR nuclear location and the upregulation of caudal-related homeo-box 2 (CDX2) expression [104].